Xped Limited (ASX:XPE) is currently undertaking a Private Placement to sophisticated investors.
XPED Ltd (ASX:XPE) is an Australian Internet of Things ("IoT") technology business. Xped has developed revolutionary and patent-protected technology that allows any consumer, regardless of their technical capability, to connect, monitor and control devices and appliances found in our everyday environment. It's as simple as two people shaking hands. By enabling the Internet of Things, Xped's ADRC platform will bring benefit to Manufacturers, Retailers, Service Providers, and Consumers.
Xped Limited (ASX:XPE) is pleased to release the attached presentation being used for investor meetings.
XPED Ltd (ASX:XPE) is pleased to announce that their subsidiary JCT Healthcare has been successful in winning a $649,000 tender with Renewal SA.
XPED Ltd (ASX:XPE) provides the Company's CEO letter to Shareholders.
Xped Limited (ASX:XPE), the Internet of Things Technology Company has today released its Quarterly Activities Report for the quarter.
Xped Limited (ASX:XPE) is pleased to provide this market update regarding recent progress and developments.
Xped Limited (ASX:XPE) is pleased to confirm that acceptances of applications pursuant to Bonus Option Offer announced on 18 May 2017 have been received from Eligible Shareholders for a total of 149,285,289 Bonus Options. The valid acceptances give rise to a shortfall of 419,391,619 new Options. The Bonus Option Offer closed on Tuesday, 11 July 2017.
XPED Ltd (ASX:XPE) announces that the Share Sale Facility (the Facility) of ordinary shares for shareholders who hold less than a "marketable parcel" closed at 5pm (AEST) on 23 June 2017.
XPED Ltd (ASX:XPE) provides the following update in respect of Media Intelligence Co. Pty Ltd.
XPED Ltd (ASX:XPE) is pleased to confirm that it has today lodged a prospectus for the non-renounceable pro rata offer to shareholders of one Bonus Option for every two shares held in the Company, initially announced on 18 May 2017. The Bonus Options have an issue price of $0.001 each and will be exercisable at $0.04 each within six months of issue (18 January 2018).